Issues for simulation of galactic cosmic ray exposures for radiobiological research at ground-based accelerators
Myung-Hee Y Kim, Adam Rusek, and Francis A Cucinotta*
Spatial separation of Plk1 phosphorylation and activity
Wytse Bruinsma, Melinda Aprelia, Jolanda Kool, Libor Macurek, Arne Lindqvist, and Rene Medema*
Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer
Charles A Kunos, Tracy M Sherertz, Mazen Mislmani, Rodney J Ellis, Simon S Lo*, Steven E Waggoner, Kristine M Zanotti, Karin Herrmann, and Robert L Debernardo
Hedgehog inhibitors in rhabdomyosarcoma: a comparison of 4 compounds and responsiveness of 4 cell lines
Rosalie Ridzewski, Diana Rettberg, Kai Dittmann, Nicole Cuvelier, Simone Fulda, and Heidi Hahn*
CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase 2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer
Jung-Min Lee*, Jane B. Trepel, Peter Choyke, Liang Cao, Tristan M Sissung, Nicole Houston, Minshu Yu, William D Figg, Ismail Turkbey, Seth M. Steinberg, Min-Jung Lee, Percy Ivy, Joyce Liu, Ursula Matulonis, and Elise Kohn
Oncogenic RAS mutants confer resistance of rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death
Christina Schott, Ulrike Graab, Nicole Cuvelier, Heidi Hahn, and Simone Fulda*
Concurrent diabetes mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer
Jeffrey Shevach, Emily Jane Gallagher, Teena Kochukoshy, Victoria Gresia, Manpreet Brar, Matthew D Galsky, and William K Oh*
Inhibitors of pan PI3K signaling synergize with BRAF or MEK inhibitors to prevent BRAF-mutant melanoma cell growth
Melanie Sweetlove, Emma Wrightson, Sharada Kolekar, Gordon W. Rewcastle, Bruce C. Baguley, Peter R. Shepherd, and Stephen M. F. Jamieson*
Single-cell phenotypic characterization of human pituitary GHomas and non-functioning adenomas based on hormone content and calcium responses to hypothalamic releasing hormones
Laura Senovilla, Lucía Núñez, Jose María de Campos, Daniel A De Luis, Enrique Romero, Javier García-Sancho, and Carlos Villalobos*
Socioeconomic status and childhood leukemia incidence
Martin Adam*, Claudia Kuehni, Adrian Spoerri, Kurt Schmidlin, Fabienne Gumy-Pause, Pierluigi Brazzola, Nicole Probst-Hensch, and Marcel Zwahlen